UTHR-United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
This company came out on one of my scans not long ago and a careful examination of the chart was very encouraging. Then I started reading about the woman who founded them, Martine Rothblatt, and liked what I saw. I think this one really has potential. |
